FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Int J Mol Sci / Eastern Equine Encephalitis Virus: The Importance of Metabol...
International journal of molecular sciences2024; 25(24); 13318; doi: 10.3390/ijms252413318

Eastern Equine Encephalitis Virus: The Importance of Metabolism and Aging.

Abstract: Eastern equine encephalitis virus (EEEV) is a mosquito-transmitted alphavirus that, among humans, can cause a severe and often fatal illness. The zoonotic EEEV enzootic cycle involves a cycle of transmission between and avian hosts, frequently resulting in spillover to dead-end vertebrate hosts such as humans and horses. Interestingly, it has been described that the W132G mutation of the very low-density lipoprotein receptor (VLDLR), the receptor of EEEV, significantly enhanced the VLDLR-mediated cell attachment of EEEV. The patient's metabolism plays a pivotal role in shaping the complex landscape of viral zoonosis. EEEV represents a significant public health concern due to its severe clinical outcomes, challenging epidemiological characteristics, and certain risk factors that heighten susceptibility among specific populations or age groups. Age is one of several predictors that can impact the outcome of EEEV infection; juvenile animals appear to be particularly vulnerable to severe disease. This has also been observed in natural infections, as children are often the most severely impacted humans. The aim of this piece is to shed light on the intricate relationship between human metabolism and the Eastern equine encephalitis virus.
Get Full Text
Publication Date: 2024-12-12 PubMed ID: 39769082PubMed Central: PMC11680025DOI: 10.3390/ijms252413318Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses the significance of metabolism and aging in the Eastern equine encephalitis virus (EEEV), a mosquito-borne virus that can cause severe illness in humans. The article particularly focuses on the effect of a mutation in the VLDLR receptor, which EEEV uses to attach to cells, and the susceptibility of certain population groups, such as children and those with metabolic factors.

Eastern Equine Encephalitis Virus and its Mechanism

  • EEEV is an alphavirus transmitted by mosquitoes that can cause severe and often fatal diseases in humans.
  • Its transmission cycle typically involves transmission between mosquitoes and avian hosts. It can occasionally “spill over” into other vertebrate hosts that don’t further its transmission, such as humans and horses.
  • This spillover causes the disease among humans and represents a significant public health concern.

W132G Mutation and Its Impact

  • A mutation known as the W132G mutation in the very low-density lipoprotein receptor (VLDLR), which EEEV uses to attach to cells, has been observed to enhance EEEV’s attachment to cells.
  • This impact of this mutation on EEEV infection and diseases progression is a focus of this research. It could provide clues to the differing severities of disease seen among different patients.

Role of Metabolism in Disease Progression

  • The patient’s metabolism plays a crucial role in the complexity of viral zoonosis, particularly with regards to EEEV.
  • Understanding the interaction between an individual’s metabolism and EEEV could potentially explain why some people are more susceptible to severe disease.

Influence of Age on Susceptibility to EEEV

  • Age has been identified as a significant predictor of the outcome of EEEV infection.
  • Young animals and children have been found to be particularly vulnerable to severe EEEV disease. This aspect of age as a risk factor is a key area of focus in this research.

Objective of the Research

  • The aim of this research is to further understand the complex relationship between human metabolism, aging, and EEEV.
  • By doing so, it hopes to shed light on why certain populations are more susceptible to severe disease and improve public health strategies to tackle EEEV.

Cite This Article

APA
Kordowitzki P. (2024). Eastern Equine Encephalitis Virus: The Importance of Metabolism and Aging. Int J Mol Sci, 25(24), 13318. https://doi.org/10.3390/ijms252413318

Publication

International journal of molecular sciences
ISSN: 1422-0067
NlmUniqueID: 101092791
Country: Switzerland
Language: English
Volume: 25
Issue: 24
PII: 13318

Researcher Affiliations

Kordowitzki, Pawel
  • Department of Preclinical and Basic Sciences, Faculty of Biological and Veterinary Sciences, Nicolaus Copernicus University, 87-100 Torun, Poland.
  • Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.

MeSH Terms

  • Animals
  • Humans
  • Aging / metabolism
  • Aging / physiology
  • Encephalitis Virus, Eastern Equine / metabolism
  • Encephalomyelitis, Eastern Equine / metabolism
  • Encephalomyelitis, Eastern Equine / virology
  • Encephalomyelitis, Equine / virology
  • Horses / virology

Grant Funding

  • 75/2022 / IDUB Nicolaus Copernicu University

Conflict of Interest Statement

The author declares no conflicts of interest.

References

This article includes 66 references
  1. Morens DM, Folkers GK, Fauci AS. Eastern Equine Encephalitis Virus—Another Emergent Arbovirus in the United States. N. Engl. J. Med. 2019;381:1989–1992.
    doi: 10.1056/NEJMp1914328pubmed: 31747726google scholar: lookup
  2. Tan Y, Lam TT, Heberlein-Larson LA, Smole SC, Auguste AJ, Hennigan S, Halpin RA, Fedorova N, Puri V, Stockwell TB. Large-Scale Complete-Genome Sequencing and Phylodynamic Analysis of Eastern Equine Encephalitis Virus Reveals Source-Sink Transmission Dynamics in the United States. J. Virol. 2018;92:e00074-18.
    doi: 10.1128/JVI.00074-18pmc: PMC5974483pubmed: 29618651google scholar: lookup
  3. Fagre AC, Soto RA, Magleby R, Cuadera MKQ, Sun A, Cervantes K, Crans SC, Panella NA, Kenney JL, Angelus A. Enhancing Eastern Equine Encephalitis Virus Surveillance in New Jersey: Optimized Collection of Culiseta melanura. J. Am. Mosq. Control Assoc. 2024;40:92–101.
    doi: 10.2987/23-7148pubmed: 38587266google scholar: lookup
  4. Magalhaes T, Hamer GL, de Carvalho-Leandro D, Ribeiro VML, Turell MJ. Uncertainties Surrounding Madariaga Virus, a Member of the Eastern Equine Encephalitis Virus Complex. Vector Borne Zoonotic Dis. 2024.
    doi: 10.1089/vbz.2023.0162pubmed: 38717063google scholar: lookup
  5. Bakhiyi B, Irace-Cima A, Ludwig A, Rakotoarinia MR, Therrien C, Dusfour I, Adam-Poupart A. Public health contributions of entomological surveillance of West Nile virus (WNV) and other mosquito-borne arboviruses in a context of climate change. Can. Commun. Dis. Rep. 2024;50:294–304.
    doi: 10.14745/ccdr.v50i09a02pmc: PMC11383429pubmed: 39257840google scholar: lookup
  6. Sohail A, Waqas FH, Braubach P, Czichon L, Samir M, Iqbal A, de Araujo L, Pleschka S, Steinert M, Geffers R. Differential transcriptomic host responses in the early phase of viral and bacterial infections in human lung tissue explants ex vivo. Respir. Res. 2024;25:369.
    doi: 10.1186/s12931-024-02988-8pmc: PMC11471021pubmed: 39395995google scholar: lookup
  7. Verdin E, Hirschey MD, Finley LW, Haigis MC. Sirtuin regulation of mitochondria: Energy production, apoptosis, and signaling. Trends Biochem. Sci. 2010;35:669–675.
    doi: 10.1016/j.tibs.2010.07.003pmc: PMC2992946pubmed: 20863707google scholar: lookup
  8. Sun Z, Wang Y, Jin X, Li S, Qiu HJ. Crosstalk between Dysfunctional Mitochondria and Proinflammatory Responses during Viral Infections. Int. J. Mol. Sci. 2024;25:9206.
    doi: 10.3390/ijms25179206pmc: PMC11395300pubmed: 39273156google scholar: lookup
  9. Prasada Kabekkodu S, Chakrabarty S, Jayaram P, Mallya S, Thangaraj K, Singh KK, Satyamoorthy K. Severe acute respiratory syndrome coronaviruses contributing to mitochondrial dysfunction: Implications for post-COVID complications. Mitochondrion. 2023;69:43–56.
    doi: 10.1016/j.mito.2023.01.005pmc: PMC9854144pubmed: 36690315google scholar: lookup
  10. Gay L, Desquiret-Dumas V, Nagot N, Rapenne C, Van de Perre P, Reynier P, Molès JP. Long-term persistence of mitochondrial dysfunctions after viral infections and antiviral therapies: A review of mechanisms involved. J. Med. Virol. 2024;96:e29886.
    doi: 10.1002/jmv.29886pubmed: 39246064google scholar: lookup
  11. Jiao L, Shao W, Quan W, Xu L, Liu P, Yang J, Peng X. iPLA2β loss leads to age-related cognitive decline and neuroinflammation by disrupting neuronal mitophagy. J. Neuroinflamm. 2024;21:228.
    doi: 10.1186/s12974-024-03219-zpmc: PMC11409585pubmed: 39294744google scholar: lookup
  12. Raabe V, Lai L, Xu Y, Huerta C, Wang D, Pouch SM, Burke CW, Piper AE, Gardner CL, Glass PJ. The Immune Response to Eastern Equine Encephalitis Virus Acquired Through Organ Transplantation. Front. Microbiol. 2020;11:561530.
    doi: 10.3389/fmicb.2020.561530pmc: PMC7541818pubmed: 33072022google scholar: lookup
  13. Cao D, Ma B, Cao Z, Xu X, Zhang X, Xiang Y. The receptor VLDLR binds Eastern Equine Encephalitis virus through multiple distinct modes. Nat. Commun. 2024;15:6866.
    doi: 10.1038/s41467-024-51293-xpmc: PMC11316819pubmed: 39127734google scholar: lookup
  14. Adams LJ, Raju S, Ma H, Gilliland T Jr, Reed DS, Klimstra WB, Fremont DH, Diamond MS. Structural and functional basis of VLDLR usage by Eastern equine encephalitis virus. Cell. 2024;187:360–374.e19.
    doi: 10.1016/j.cell.2023.11.031pmc: PMC10843625pubmed: 38176410google scholar: lookup
  15. Pouch SM, Katugaha SB, Shieh WJ, Annambhotla P, Walker WL, Basavaraju SV, Jones J, Huynh T, Reagan-Steiner S, Bhatnagar J. Transmission of Eastern Equine Encephalitis Virus from an Organ Donor to Three Transplant Recipients. Clin. Infect. Dis. 2019;69:450–458.
    doi: 10.1093/cid/ciy923pmc: PMC6488434pubmed: 30371754google scholar: lookup
  16. Beddingfield BJ, Plante KS, Plante JA, Weaver SC, Bose S, Krzykwa C, Chirichella N, Redmann RK, Seiler SZ, Dufour J. MVA-based vaccines are protective against lethal eastern equine encephalitis virus aerosol challenge in cynomolgus macaques. NPJ Vaccines 2024;9:47.
    doi: 10.1038/s41541-024-00842-ypmc: PMC10899228pubmed: 38413593google scholar: lookup
  17. Bristow CL. Silencing Very-Low-Density Lipoprotein Receptor Reveals Alpha-1 Antitrypsin Role in HIV Infectivity. Methods Mol. Biol. 2024;2750:175–184.
    doi: 10.1007/978-1-0716-3605-3_16pubmed: 38108977google scholar: lookup
  18. Echeverría P, Guardiola M, González M, Vallvé JC, Puig J, Bonjoch A, Clotet B, Ribalta J, Negredo E. Association between lipid genetic and immunological status in chronically HIV-infected patients. J. Int. Aids Soc. 2014;17((Suppl. S3)):19555.
    doi: 10.7448/IAS.17.4.19555pmc: PMC4224882pubmed: 25394062google scholar: lookup
  19. Yang X, Chen J, Wang J, Ma S, Feng W, Wu Z, Guo Y, Zhou H, Mi W, Chen W. Very-low-density lipoprotein receptor-enhanced lipid metabolism in pancreatic stellate cells promotes pancreatic fibrosis. Immunity 2022;55:1185–1199.e8.
    doi: 10.1016/j.immuni.2022.06.001pubmed: 35738281google scholar: lookup
  20. Takeuchi O, Akira S. RIG-I-like antiviral protein in flies. Nat. Immunol. 2008;9:1327–1328.
    doi: 10.1038/ni1208-1327pubmed: 19008930google scholar: lookup
  21. Ouda R, Onomoto K, Takahasi K, Edwards MR, Kato H, Yoneyama M, Fujita T. Retinoic acid-inducible gene I-inducible miR-23b inhibits infections by minor group rhinoviruses through down-regulation of the very low density lipoprotein receptor. J. Biol. Chem. 2011;286:26210–26219.
    doi: 10.1074/jbc.M111.229856pmc: PMC3138319pubmed: 21642441google scholar: lookup
  22. Wu IT, Yeh WJ, Huang WC, Yang HY. Very low-carbohydrate diet with higher protein ratio improves lipid metabolism and inflammation in rats with diet-induced nonalcoholic fatty liver disease. J. Nutr. Biochem. 2024;126:109583.
    doi: 10.1016/j.jnutbio.2024.109583pubmed: 38244701google scholar: lookup
  23. Hill V, Koch RT, Bialosuknia SM, Ngo K, Zink SD, Koetzner CA, Maffei JG, Dupuis AP, Backenson PB, Oliver J. Dynamics of eastern equine encephalitis virus during the 2019 outbreak in the Northeast United States. Curr. Biol. 2023;33:2515–2527.e6.
    doi: 10.1016/j.cub.2023.05.047pmc: PMC10316540pubmed: 37295427google scholar: lookup
  24. Sallam MF, Whitehead S, Barve N, Bauer A, Guralnick R, Allen J, Tavares Y, Gibson S, Linthicum KJ, Giordano BV. Co-occurrence probabilities between mosquito vectors of West Nile and Eastern equine encephalitis viruses using Markov Random Fields (MRFcov). Parasites Vectors 2023;16:10.
    doi: 10.1186/s13071-022-05530-1pmc: PMC9830877pubmed: 36627717google scholar: lookup
  25. Aguilar PV, Robich RM, Turell MJ, O’Guinn ML, Klein TA, Huaman A, Guevara C, Rios Z, Tesh RB, Watts DM. Endemic eastern equine encephalitis in the Amazon region of Peru. Am. J. Trop. Med. Hyg. 2007;76:293–298.
    doi: 10.4269/ajtmh.2007.76.293pubmed: 17297038google scholar: lookup
  26. Xie L, Wu Y, Jiang J, Zhou H. An improved alphaviruses-specific RT-qPCR facilitates monitoring and prevention of alphaviruses. J. Med. Virol. 2024;96:e29788.
    doi: 10.1002/jmv.29788pubmed: 38982767google scholar: lookup
  27. Davis E, Velez J, Hamik J, Fitzpatrick K, Haley J, Eschliman J, Panella A, Staples JE, Lambert A, Donahue M. Evidence of Lineage 1 and 3 West Nile Virus in Person with Neuroinvasive Disease, Nebraska, USA, 2023. Emerg. Infect. Dis. 2024;30:2090–2098.
    doi: 10.3201/eid3010.240595pmc: PMC11431902pubmed: 39320165google scholar: lookup
  28. Ardakani R, Jia L, Matthews E, Thakur KT. Therapeutic advances in neuroinfectious diseases. Ther. Adv. Infect. Dis. 2024;11:20499361241274246.
    doi: 10.1177/20499361241274246pmc: PMC11418331pubmed: 39314743google scholar: lookup
  29. Abu Melha AA, Aldress AS, Alamri F, Aljomah LS, Hommady R, Al-Rumayyan A, Albassam F. Prognostic factors and treatment outcomes in pediatric autoimmune encephalitis: A multicenter study. Front. Neurol. 2024;15:1441033.
    doi: 10.3389/fneur.2024.1441033pmc: PMC11402692pubmed: 39286808google scholar: lookup
  30. Deresiewicz RL, Thaler SJ, Hsu L, Zamani AA. Clinical and neuroradiographic manifestations of eastern equine encephalitis. N. Engl. J. Med. 1997;336:1867–1874.
    doi: 10.1056/NEJM199706263362604pubmed: 9197215google scholar: lookup
  31. Lindsey NP, Martin SW, Staples JE, Fischer M. Notes from the Field: Multistate Outbreak of Eastern Equine Encephalitis Virus—United States, 2019. MMWR Morb. Mortal. Wkly. Rep. 2020;69:50–51.
    doi: 10.15585/mmwr.mm6902a4pmc: PMC6973353pubmed: 31945032google scholar: lookup
  32. Cho JJ, Wong JK, Henkel J, DeJesus RO, Nazario-Lopez B. Acute Seroconversion of Eastern Equine Encephalitis Coinfection with California Serogroup Encephalitis Virus. Front. Neurol. 2019;10:242.
    doi: 10.3389/fneur.2019.00242pmc: PMC6433933pubmed: 30941092google scholar: lookup
  33. Silverman MA, Misasi J, Smole S, Feldman HA, Cohen AB, Santagata S, McManus M, Ahmed AA. Eastern equine encephalitis in children, Massachusetts and New Hampshire, USA, 1970–2010. Emerg. Infect. Dis. 2013;19:194–201; quiz 352.
    doi: 10.3201/eid1902.120039pmc: PMC3559032pubmed: 23343480google scholar: lookup
  34. González MA, Chaskopoulou A, Georgiou L, Frontera E, Cáceres F, Masia M, Gutiérrez-Climente R, Ambert GL, Osório H, Seixas G. Mosquito management strategies in European rice fields: Environmental and public health perspectives. J. Environ. Manag. 2024;370:122534.
    doi: 10.1016/j.jenvman.2024.122534pubmed: 39316873google scholar: lookup
  35. Asadian A, Zakeri A, Dadras M, Mahdavi S. Investigating knowledge, attitude, and self-care behavior concerning Aedes mosquito bites and the knowledge of dengue fever among Hormozgan residents in the south of Iran. J. Educ. Health Promot. 2024;13:219.
    doi: 10.4103/jehp.jehp_514_23pmc: PMC11410174pubmed: 39297102google scholar: lookup
  36. Kalmouni J, Will JB Jr, Townsend J, Paaijmans KP. Temperature and time of host-seeking activity impact the efficacy of chemical control interventions targeting the West Nile virus vector, Culex tarsalis. PLoS Negl. Trop. Dis. 2024;18:e0012460.
    doi: 10.1371/journal.pntd.0012460pmc: PMC11392387pubmed: 39213461google scholar: lookup
  37. Ma L, Han Q, Cheng L, Song H, Qiang R, Xu P, Gao F, Zhu L, Xu J. Altered mitochondrial mass and low mitochondrial membrane potential of immune cells in patients with HBV infection and correlation with liver inflammation. Front. Immunol. 2024;15:1477646.
    doi: 10.3389/fimmu.2024.1477646pmc: PMC11621101pubmed: 39650657google scholar: lookup
  38. Chen Y, Liang Q, Wei L, Zhou X. Double infection of Nicotiana benthamiana with AMV and WCMV increases both virus concentrations and synergistically changes both host organelle ultrastructure and chlorophyll content. Microb. Pathog. 2024;196:106956.
    doi: 10.1016/j.micpath.2024.106956pubmed: 39307196google scholar: lookup
  39. Hofstadter WA, Cook KC, Tsopurashvili E, Gebauer R, Pražák V, Machala EA, Park JW, Grünewald K, Quemin ERJ, Cristea IM. Infection-induced peripheral mitochondria fission drives ER encapsulations and inter-mitochondria contacts that rescue bioenergetics. Nat. Commun. 2024;15:7352.
    doi: 10.1038/s41467-024-51680-4pmc: PMC11347691pubmed: 39187492google scholar: lookup
  40. Zhao Y, Ding C, Zhu Z, Wang W, Wen W, Favoreel HW, Li X. Pseudorabies virus infection triggers mitophagy to dampen the interferon response and promote viral replication. J. Virol. 2024;98:e0104824.
    doi: 10.1128/jvi.01048-24pmc: PMC11494983pubmed: 39212384google scholar: lookup
  41. Chen Y, Zhang M, Liu Z, Zhang N, Wang Q. Ursodeoxycholic Acid Platinum(IV) Conjugates as Antiproliferative and Antimetastatic Agents: Remodel the Tumor Microenvironment through Suppressing JAK2/STAT3 Signaling. J. Med. Chem. 2024;67:17551–17567.
    doi: 10.1021/acs.jmedchem.4c01549pubmed: 39292635google scholar: lookup
  42. Ren Z, Zhang X, Ding T, Zhong Z, Hu H, Xu Z, Deng J. Mitochondrial Dynamics Imbalance: A Strategy for Promoting Viral Infection. Front. Microbiol. 2020;11:1992.
    doi: 10.3389/fmicb.2020.01992pmc: PMC7472841pubmed: 32973718google scholar: lookup
  43. Li H, Dai X, Zhou J, Wang Y, Zhang S, Guo J, Shen L, Yan H, Jiang H. Mitochondrial dynamics in pulmonary disease: Implications for the potential therapeutics. J. Cell. Physiol. 2024;239:e31370.
    doi: 10.1002/jcp.31370pubmed: 38988059google scholar: lookup
  44. Shin HJ, Lee W, Ku KB, Yoon GY, Moon HW, Kim C, Kim MH, Yi YS, Jun S, Kim BT. SARS-CoV-2 aberrantly elevates mitochondrial bioenergetics to induce robust virus propagation. Signal Transduct. Target. Ther. 2024;9:125.
    doi: 10.1038/s41392-024-01836-xpmc: PMC11088672pubmed: 38734691google scholar: lookup
  45. Narala VR, Narala SR, Aiya Subramani P, Panati K, Kolliputi N. Role of mitochondria in inflammatory lung diseases. Front. Pharmacol. 2024;15:1433961.
    doi: 10.3389/fphar.2024.1433961pmc: PMC11368744pubmed: 39228517google scholar: lookup
  46. Li R, Deng H, Han Y, Tong Y, Hou Y, Huang T, Xiao M, Deng L, Zhao X, Chen Y. Therapeutic effects of Lianhua Qingke on COPD and influenza virus-induced exacerbation of COPD are associated with the inhibition of NF-κB signaling and NLRP3 inflammasome responses. Int. Immunopharmacol. 2024;142:113213.
    doi: 10.1016/j.intimp.2024.113213pubmed: 39317049google scholar: lookup
  47. de Torre-Minguela C, Mesa Del Castillo P, Pelegrín P. The NLRP3 and Pyrin Inflammasomes: Implications in the Pathophysiology of Autoinflammatory Diseases. Front. Immunol. 2017;8:43.
    doi: 10.3389/fimmu.2017.00043pmc: PMC5271383pubmed: 28191008google scholar: lookup
  48. Wang Y, Chen J, Zheng Y, Jiang J, Wang L, Wu J, Zhang C, Luo M. Glucose metabolite methylglyoxal induces vascular endothelial cell pyroptosis via NLRP3 inflammasome activation and oxidative stress in vitro and in vivo. Cell. Mol. Life Sci. 2024;81:401.
    doi: 10.1007/s00018-024-05432-8pmc: PMC11399538pubmed: 39269632google scholar: lookup
  49. Kurmangaliyeva S, Baktikulova K, Tkachenko V, Seitkhanova B, Shapambayev N, Rakhimzhanova F, Almagambetova A, Kurmangaliyev K. An Overview of Hexavalent Chromium-Induced Necroptosis, Pyroptosis, and Ferroptosis. Biol. Trace Elem. Res. 2024.
    doi: 10.1007/s12011-024-04376-1pubmed: 39287767google scholar: lookup
  50. Hari A, Zhang Y, Tu Z, Detampel P, Stenner M, Ganguly A, Shi Y. Activation of NLRP3 inflammasome by crystalline structures via cell surface contact. Sci. Rep. 2014;4:7281.
    doi: 10.1038/srep07281pmc: PMC4250918pubmed: 25445147google scholar: lookup
  51. Peggion C, Calì T, Brini M. Mitochondria Dysfunction and Neuroinflammation in Neurodegeneration: Who Comes First?. Antioxidants 2024;13:240.
    doi: 10.3390/antiox13020240pmc: PMC10885966pubmed: 38397838google scholar: lookup
  52. An W, Lakhina S, Leong J, Rawat K, Husain M. Host Innate Antiviral Response to Influenza A Virus Infection: From Viral Sensing to Antagonism and Escape. Pathogens 2024;13:561.
    doi: 10.3390/pathogens13070561pmc: PMC11280125pubmed: 39057788google scholar: lookup
  53. Guan Z, Li H, Zhang C, Huang Z, Ye M, Zhang Y, Li S, Peng K. RVFV virulence factor NSs triggers the mitochondrial MCL-1-BAK axis to activate pathogenic NLRP3 pyroptosis. PLoS Pathog. 2024;20:e1012387.
    doi: 10.1371/journal.ppat.1012387pmc: PMC11364418pubmed: 39213434google scholar: lookup
  54. Dai Y, Xu X, Huo X, Schuitemaker JHN, Faas MM. Differential effect of lead and cadmium on mitochondrial function and NLRP3 inflammasome activation in human trophoblast. J. Physiol. 2024.
    doi: 10.1113/JP286755pubmed: 39197088google scholar: lookup
  55. Gaensbauer JT, Lindsey NP, Messacar K, Staples JE, Fischer M. Neuroinvasive arboviral disease in the United States: 2003 to 2012. Pediatrics 2014;134:e642–e650.
    doi: 10.1542/peds.2014-0498pmc: PMC5662468pubmed: 25113294google scholar: lookup
  56. Mukhopadhyay K, Sengupta M, Misra SC, Majee K. Trends in emerging vector-borne viral infections and their outcome in children over two decades. Pediatr. Res. 2024;95:464–479.
    doi: 10.1038/s41390-023-02866-xpubmed: 37880334google scholar: lookup
  57. García-de la Rosa MT, Wong-Baeza I, Arriaga-Pizano LA. Participación de la inmunosenescencia y del inflammaging en enfermedades asociadas al envejecimiento [The role of immunosenescence and inflammaging in aging-associated diseases]. Rev. Médica Inst. Mex. Seguro Soc. 2024;62:1–8.
    doi: 10.5281/zenodo.12668114pubmed: 39577835google scholar: lookup
  58. Chang ST, Chuang YF, Li AH, Fan YT, Liao MR, Chen IY, Hung RW, Yang TO, Chiu YL. Age-dependent immune profile in healthy individuals: An original study, systematic review and meta-analysis. Immun. Ageing. 2024;21:75.
    doi: 10.1186/s12979-024-00480-xpmc: PMC11520839pubmed: 39472926google scholar: lookup
  59. Ginefra P, Hope HC, Lorusso G, D’Amelio P, Vannini N. The immunometabolic roots of aging. Curr. Opin. Immunol. 2024;91:102498.
    doi: 10.1016/j.coi.2024.102498pubmed: 39461330google scholar: lookup
  60. Pawelec G. Age and Immunity: What Is “Immunosenescence”?. Exp. Gerontol. 2018;105:4–9.
    doi: 10.1016/j.exger.2017.10.024pubmed: 29111233google scholar: lookup
  61. Chen S, Liao Z, Xu P. Mitochondrial Control of Innate Immune Responses. Front. Immunol. 2023;14:1166214.
    doi: 10.3389/fimmu.2023.1166214pmc: PMC10267745pubmed: 37325622google scholar: lookup
  62. Liu Z, Liang Q, Ren Y, Guo C, Ge X, Wang L, Cheng Q, Luo P, Zhang Y, Han X. Immunosenescence: Molecular Mechanisms and Diseases. Signal Transduct. Target. Ther. 2023;8:200.
    doi: 10.1038/s41392-023-01451-2pmc: PMC10182360pubmed: 37179335google scholar: lookup
  63. Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G. Inflamm-aging: An Evolutionary Perspective on Immunosenescence. Ann. N. Y. Acad. Sci. 2000;908:244–254.
    doi: 10.1111/j.1749-6632.2000.tb06651.xpubmed: 10911963google scholar: lookup
  64. Freund A, Orjalo AV, Desprez PY, Campisi J. Inflammatory Networks during Cellular Senescence: Causes and Consequences. Trends Mol. Med. 2010;16:238–246.
    doi: 10.1016/j.molmed.2010.03.003pmc: PMC2879478pubmed: 20444648google scholar: lookup
  65. Burke CW, Erwin-Cohen RA, Goodson AI, Wilhelmsen C, Edmundson JA, White CE, Glass PJ. Efficacy of Western, Eastern, and Venezuelan Equine Encephalitis (WEVEE) Virus-Replicon Particle (VRP) Vaccine against WEEV in a Non-Human Primate Animal Model. Viruses 2022;14:1502.
    doi: 10.3390/v14071502pmc: PMC9321360pubmed: 35891482google scholar: lookup
  66. Nguyen TL, Kim H. Designing a Multiepitope Vaccine against Eastern Equine Encephalitis Virus: Immunoinformatics and Computational Approaches. ACS Omega 2023;9:1092–1105.
    doi: 10.1021/acsomega.3c07322pmc: PMC10785064pubmed: 38222668google scholar: lookup

Citations

This article has been cited 0 times.
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.